SS
RNXT icon

Steve Schonfeld’s RenovoRx RNXT Stock Holding History

Steve Schonfeld’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,569
Closed -$125K – 2477
2021
Q3 		$125K Buy
+20,569
New +$171K ﹤0.01% 1889

Other funds holding RNXT

BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return

Steve Schonfeld's RNXT Position: Q4 2021 in Review

Steve Schonfeld sold out of RenovoRx (RNXT) in Q4 2021, closing a stake of 20,569 shares — an estimated $125K sold.

Steve Schonfeld first reported a position in RNXT in Q3 2021 and held it in 1 quarter. The position peaked at $125K in Q3 2021. 9 funds tracked by Wall St. Rank hold RNXT as of Q4 2021.

  • Steve Schonfeld reported no remaining RenovoRx position as of Q4 2021 after selling out during the quarter.
  • Steve Schonfeld sold 20,569 RenovoRx shares in Q4 2021, an estimated $125K.
  • Steve Schonfeld first reported a position in RenovoRx in Q3 2021 and held it in 1 quarter.
  • Steve Schonfeld's RenovoRx position peaked at $125K in Q3 2021.
  • 9 funds tracked by Wall St. Rank held RenovoRx as of Q4 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.